These findings reveal specific cell types, namely CD4 T cells, CD8 T cells, Granulocytes, and several brain-derived cells, where the prioritized proteins may have a relevant role in MS pathogenesis, validating their significance and highlighting their potential as therapeutic targets. Here, CD8A is linked to myeloid sarcoma.